Results 21 to 30 of about 6,030,066 (175)

Leishmaniasis in refugee and local Pakistani populations. [PDF]

open access: yes, 2004
The epidemiology of anthroponotic cutaneous leishmaniasis was investigated in northwest Pakistan. Results suggested similar patterns of endemicity in both Afghan refugee and Pakistani populations and highlighted risk factors and household clustering of ...
Said Agha   +15 more
core   +1 more source

Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan. [PDF]

open access: yes, 2003
A prevalence survey in Kabul City showed that 2.7% and 21.9% of persons have active leishmaniasis lesions or scars, respectively. Incidence of disease was estimated to be 2.9% (29 cases/1,000 persons per year; 95% confidence interval 0.018 to 0.031 ...
Reithinger, Richard   +11 more
core   +1 more source

Risk factors for anthroponotic cutaneous Leishmaniasis at the household level in Kabul, Afghanistan. [PDF]

open access: yes, 2010
BACKGROUND: Kabul, Afghanistan, is the largest focus of anthroponotic cutaneous leishmaniasis (ACL) in the world. ACL is a protozoan disease transmitted to humans by the bite of phlebotomine sand flies.
Reithinger, Richard   +8 more
core   +2 more sources

Age-related alteration of arginase activity impacts on severity of leishmaniasis. [PDF]

open access: yes, 2008
BACKGROUND: The leishmaniases are a group of vector-borne parasitic diseases that represent a major international public health problem; they belong to the most neglected tropical diseases and have one of the highest rates of morbidity and mortality. The
Asrat Hailu   +40 more
core   +2 more sources

Treatment of leishmaniasis with chemotherapy and vaccine: a mathematical model

open access: yesJournal of Biological Dynamics, 2023
Leishmaniasis, an infectious disease, manifests itself mostly in two forms, cutaneous leishmaniasis (CL) and, a more severe and potentially deadly form, visceral leishmaniasis (VL).
Nourridine Siewe, Avner Friedman
doaj   +1 more source

Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting. [PDF]

open access: yes, 2007
BACKGROUND: Although Kabul city, Afghanistan, is currently the worldwide largest focus of cutaneous leishmaniasis (CL) with an estimated 67,500 cases, donor interest in CL has been comparatively poor because the disease is non-fatal. Since 1998 HealthNet
Reithinger, Richard   +5 more
core   +2 more sources

Healed Lesions of Human Cutaneous Leishmaniasis Caused By Leishmania major Do Not Shelter Persistent Residual Parasites

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
In human cutaneous leishmaniasis (HCL) caused by Leishmania (L.) major, the cutaneous lesions heal spontaneously and induce a Th1-type immunity that confers solid protection against reinfection.
Rabiaa M. Sghaier   +31 more
doaj   +1 more source

Assessment of Leishmaniasis notification system in Santiago del Estero, Argentina, 1990-1993. [PDF]

open access: yes, 2001
Using a capture-recapture method, this study evaluates the completeness of the cutaneous leishmaniasis (CL) surveillance system in four districts of Santiago del Estero province, Argentina, for the period 1990-1993. Four reporting sources were evaluated:
Yadón, ZE   +16 more
core   +1 more source

Protective Immunity and Vaccination Against Cutaneous Leishmaniasis

open access: yesFrontiers in Immunology, 2012
Although a great deal of knowledge has been gained from studies on the immunobiology of leishmaniasis, there is still no effective vaccine against the disease.
Ifeoma eOkwor   +4 more
doaj   +1 more source

Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2014
BACKGROUND: Leishmaniasis remains a worldwide public health problem. The limited therapeutic options, drug toxicity and reports of resistance, reinforce the need for the development of new treatment options.
Diego M Santos   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy